Bclsks Numbing

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor burns, sunburn, insect bites, scrapes, and minor skin irritations.

Limitations of Use: This product is intended for external use only and should not be applied to large areas of the body or on deep puncture wounds, animal bites, or serious burns.

Dosage and Administration

Healthcare professionals should begin by cleansing the targeted skin area thoroughly and patting it dry before application. A thin layer of the medication should then be applied to the affected area. This application may be performed up to 3 to 4 times daily, ensuring that the total daily applications do not exceed this frequency. Care should be taken to avoid applying more than the recommended amount to prevent potential adverse effects.

Contraindications

Use is contraindicated in the following situations:

Application on large areas of the body is not recommended due to the potential for systemic absorption and adverse effects. The product should not be applied to broken, blistered, or abraded skin, as this may increase the risk of irritation or systemic exposure. Additionally, individuals with a known allergy to local anesthetics, including menthol, should not use this product to avoid allergic reactions.

Warnings and Precautions

For external use only. This product is not intended for internal use, and ingestion may lead to serious health consequences.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a poison control center immediately.

Healthcare professionals should advise patients to discontinue use and consult a physician under the following circumstances: if the condition worsens or fails to improve within 7 days; if an allergic reaction to any of the product's ingredients occurs; or if symptoms persist without relief, particularly if redness or irritation develops at the application site.

No specific laboratory tests are required or suggested for the safe use of this product.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event that the condition being treated worsens or does not improve within 7 days, patients are advised to discontinue use and consult a healthcare professional.

Additionally, if an allergic reaction occurs to any of the ingredients in this product, or if symptoms do not subside, including the presence of redness or irritation, patients should stop using the product immediately and seek medical advice.

These precautions are essential to ensure the safety and well-being of patients while using this product.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Bclsks Numbing (menthol 1% numbing). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is essential.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information available regarding the use of BCLSKS NUMBING (menthol 1% numbing cream) in lactating mothers or its effects on breastfed infants. Healthcare professionals should exercise caution and consider the potential risks and benefits when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information regarding dosage adjustments, monitoring, or precautions. As such, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, given the absence of detailed guidance on its use in this population. Regular monitoring of renal function may be warranted in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential. If symptoms of overdosage are observed, appropriate interventions should be implemented based on the patient's condition.

Healthcare professionals should also consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the specific situation. Documentation of the incident and any interventions performed is crucial for ongoing patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a poison control center if the medication is swallowed. It is important to emphasize the necessity of avoiding contact with the eyes, as this could lead to irritation or injury.

Patients should be instructed not to bandage the area tightly or to use a heating pad in conjunction with the medication, as these practices may exacerbate side effects or lead to complications. Additionally, healthcare providers must stress the importance of using the medication only as directed, ensuring that patients understand the correct dosage and application methods to promote safety and efficacy.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a temperature range of 15-30°C (59-86°F) to ensure optimal stability and efficacy. Care must be taken to protect the product from excessive heat and direct sunlight, as these conditions may compromise its integrity. It is essential to use the product only as directed to maintain safety and effectiveness.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the affected area, not exceeding 3-4 times daily. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Bclsks Numbing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)